Home   >  
MAPK Pathway
  >  
Raf

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Raf

Chemical Structure Cat. No. Product Name CAS No.
LUT-014 Chemical Structure
BCP30636 LUT-014 2274819-46-2
LUT014 is a topical B-Raf Inhibitor, a proprietary, first-in-class, small molecule allowing administration of EGFR (Epidermal Growth Factor Receptor) Inhibitors to patients without interruptions caused by typical cutaneous side effects
LXH254 HCl Chemical Structure
BCP30244 LXH254 HCl LXH254HCl
LXH254 is a potent CRAF inhibitor extracted from patent WO2018051306A1, Compound A. LXH254 also is a potent BRAF inhibitor.
B-Raf inhibitor 1 dihydrochloride Chemical Structure
BCP29713 B-Raf inhibitor 1 dihydrochloride 1191385-19-9
B-Raf inhibitor 1 dihydrochloride is a novel potent and selective B-Raf inhibitor.
Takeda-6d Chemical Structure
BCP29579 Takeda-6d 1125632-93-0
Takeda-6d has potent inhibitory activity in both B-RAF with an IC50 of 7.0 nM and VEGFR2 with an IC50 of 2.2 nM.
PF-04880594 Chemical Structure
BCP21016 PF-04880594 1111636-35-1
PF-04880594 is a RAF inhibitor, which induces ERK phosphorylation and RAF dimerization in those epithelial tissues that undergo hyperplasia.
B-Raf-IN-1 Chemical Structure
BCP28151 B-Raf-IN-1 950736-05-7
B-Raf IN 1 is a highlt potent and selective B-Raf inhibitor with IC50 of 24 nM; equipotent against c-Raf (IC50= 25 nM).
HA-15 Chemical Structure
BCP28914 HA-15 1609402-14-3
HA15 displayed anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
LXH254 Chemical Structure
BCP29080 LXH254 1800398-38-2
LXH254 is a potent CRAF inhibitor extracted from patent WO2018051306A1, Compound A. LXH254 also is a potent BRAF inhibitor.
AD80 Chemical Structure
BCP25106 AD80 1384071-99-1
AD80, a multikinase inhibitor, inhibits RET, RAF,SRCand S6K, with greatly reduced mTOR activity.
BGB283 Chemical Structure
BCP09509 BGB283 1446090-77-2
BGB-283 is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRaf V600E and EGFR, respectively.
123下一页末页共 38 条记录 1 / 4 页 
0086-15971444841